MARKET

ABCL

ABCL

Abcellera Biologics Inc.
NASDAQ
11.95
-1.14
-8.68%
Opening 14:39 10/30 EDT
OPEN
12.63
PREV CLOSE
13.08
HIGH
12.91
LOW
11.75
VOLUME
2.62M
TURNOVER
--
52 WEEK HIGH
15.02
52 WEEK LOW
2.745
MARKET CAP
3.87B
P/E (TTM)
-21.9295
1D
5D
1M
3M
1Y
5Y
1D
AbCellera initiated with a Buy at Jefferies
TipRanks · 4h ago
Did Positive Phase 2 Results Just Shift AbCellera Biologics' (ABCL) Investment Narrative?
Simply Wall St · 3d ago
Weekly Report: what happened at ABCL last week (1019-1023)?
Weekly Report · 4d ago
Is AbCellera Biologics (ABCL) Undervalued After Encouraging Phase 2 Data For ABCL635?
Simply Wall St · 10/23 13:44
AbCellera to Present at Upcoming Investor Conferences in November 2026
Barchart · 10/22 15:05
AbCellera Biologics Is Up 124% Even As Sales Fell
Simply Wall St · 10/22 11:34
AbCellera Has Promising Menopause Data, But Much Of The Opportunity Is Priced In
Seeking Alpha · 10/22 08:45
Weekly Report: what happened at ABCL last week (1012-1016)?
Weekly Report · 10/19 09:08
More
About ABCL
AbCellera Biologics Inc. discovers and develops antibody medicines for indications across therapeutic areas, including cancer, metabolic and endocrine conditions, and autoimmune disorders. Its platform integrates technology, data science, infrastructure, and interdisciplinary teams to solve the challenging antibody discovery problems. It is focused on advancing an internal pipeline of programs and collaborating on drug development programs with partners. Its first two internal programs, ABCL635 and ABCL575, are in late-preclinical studies. ABCL635 is an antibody drug candidate for metabolic and endocrine conditions, and ABCL575 is an antibody drug candidate with broad potential in inflammatory conditions and autoimmune diseases and an initial indication in atopic dermatitis. ABCL575 binds OX40L to disrupt OX40/OX40L signaling, a regulator of inflammatory pathways in AD. In addition to ABCL635 and ABCL575, it is advancing a pipeline of more than 20 internal discovery programs.

Webull offers AbCellera Biologics Inc stock information, including NASDAQ: ABCL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABCL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABCL stock methods without spending real money on the virtual paper trading platform.